Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis

F Huaux, M Gharaee-Kermani, T Liu, V Morel… - The American journal of …, 2005 - Elsevier
Eotaxin-1/CCL11 and its receptor CCR3 are involved in recruitment of eosinophils to diverse
tissues, but their role in eosinophil recruitment in pulmonary fibrosis is unclear. The present …

New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy

M Gharaee-Kermani, MR Gyetko, B Hu… - Pharmaceutical …, 2007 - Springer
Abstract Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal form of
interstitial lung disease. It is characterized by injury with loss of lung epithelial cells and …

[HTML][HTML] CCAAT/enhancer-binding proteins in fibrosis: Complex roles beyond conventional understanding

L Wang, J Feng, Y Deng, Q Yang, Q Wei, D Ye, X Rong… - Research, 2022 - spj.science.org
CCAAT/enhancer-binding proteins (C/EBPs) are a family of at least six identified
transcription factors that contain a highly conserved basic leucine zipper domain and …

Tenascin-C deficiency attenuates TGF-β-mediated fibrosis following murine lung injury

WA Carey, GD Taylor, WB Dean… - American Journal of …, 2010 - journals.physiology.org
Tenascin-C (TNC) is an extracellular matrix glycoprotein of unknown function that is highly
expressed in adult lung parenchyma following acute lung injury (ALI). Here we report that …

Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis

A Unterman, AY Zhao, N Neumark… - American Journal of …, 2023 - atsjournals.org
Rationale: Changes in peripheral blood cell populations have been observed but not
detailed at single-cell resolution in idiopathic pulmonary fibrosis (IPF). Objectives: To …

[HTML][HTML] Diminished induction of skin fibrosis in mice with MCP-1 deficiency

AM Ferreira, S Takagawa, R Fresco, X Zhu… - Journal of Investigative …, 2006 - Elsevier
Scar and fibrosis are often the end result of mechanical injury and inflammatory diseases.
One chemokine that is repeatedly linked to fibrotic responses is monocyte chemoattractant …

Current and novel drug therapies for idiopathic pulmonary fibrosis

HI Adamali, TM Maher - Drug Design, Development and Therapy, 2012 - Taylor & Francis
Over the past decade, there has been a cohesive effort from patients, physicians, clinical
and basic scientists, and the pharmaceutical industry to find definitive treatments for …

Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation

MT Carulli, VH Ong, M Ponticos, X Shiwen… - Arthritis & …, 2005 - Wiley Online Library
Objective To investigate expression of the chemokine receptor CCR2 on key cell types
involved in the pathogenesis of systemic sclerosis (SSc) and to assess the potential for …

Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms

R Malaviya, HM Kipen, R Businaro, JD Laskin… - Toxicology and applied …, 2020 - Elsevier
Pulmonary fibrosis is characterized by destruction and remodeling of the lung due to an
accumulation of collagen and other extracellular matrix components in the tissue. This …

Lrp5/β-catenin signaling controls lung macrophage differentiation and inhibits resolution of fibrosis

JA Sennello, AV Misharin, AS Flozak… - American journal of …, 2017 - atsjournals.org
Previous studies established that attenuating Wnt/β-catenin signaling limits lung fibrosis in
the bleomycin mouse model of this disease, but the contribution of this pathway to distinct …